Clinical efficacy of laser combined with menstrual regulation in the treatment of female melasma: a retrospective study
- 145 Downloads
The aim of this study was to evaluate the clinical efficacy of using a Medlite C6 Q-switch Nd:YAG laser combined with menstrual regulation–based traditional Chinese medicine (TCM) in the treatment of female melasma. Forty cases of female patients with melasma, who were treated between December 2013 and December 2015 at the Jiangsu Provincial Hospital of Traditional Chinese Medicine, were reviewed retrospectively. Twenty patients received Q-switch Nd:YAG 1064 nm laser treatments combined with menstrual regulation treatments (experimental group), and 20 patients were treated only with the laser (control group). All treatments lasted for 6 months. The patients’ faces were photographed before, immediately, and 6 months after treatment. The therapeutic efficacy was assessed by the reduction in the Melasma Area and Severity Index (MASI) score and the total skin damage score, and this was then compared between the two groups. Immediately and 6 months after the treatment, both the MASI and total skin damage scores in the experimental group were significantly lower compared to those in the control group (P < 0.001). The experimental group had significantly higher basic recovery and effectiveness rates than the control group (P = 0.020 and P = 0.008, respectively) and had a significantly lower invalidity rate (P < 0.001). Results from Medlite C6 Q-switch Nd:YAG laser treatment combined with menstrual regulation are superior than those obtained using only a laser for the treatment of female melasma.
KeywordsFemale Melasma Menstrual regulation Laser Efficacy
Compliance with ethical standards
This study was approved by the Ethics Committee of the Jiangsu Provincial Hospital of Traditional Chinese Medicine. All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all the participants included in the study.
The authors declare that they have no conflict of interest.
- 6.Hofbauer Parra CA, Careta MF, Valente NY, de Sanches Osorio NE, Torezan LA (2016) Clinical and histopathologic assessment of facial melasma after low-fluence Q-switched neodymium-doped yttrium aluminium garnet laser. Dermatol Surg 42(4):507–512. https://doi.org/10.1097/dss.0000000000000653 CrossRefPubMedGoogle Scholar
- 11.Bansal C, Naik H, Kar HK, Chauhan A (2012) A comparison of low-fluence 1064-nm Q-switched Nd:YAG laser with topical 20% azelaic acid cream and their combination in melasma in Indian patients. J Cutan Aesthet Surg 5(4):266–272. https://doi.org/10.4103/0974-2077.104915 CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Shin JU, Park J, Oh SH, Lee JH (2013) Oral tranexamic acid enhances the efficacy of low-fluence 1064-nm quality-switched neodymium-doped yttrium aluminum garnet laser treatment for melasma in Koreans: a randomized, prospective trial. Dermatol Surg 39(3 Pt 1):435–442. https://doi.org/10.1111/dsu.12060 CrossRefPubMedGoogle Scholar
- 16.Group of pigmentary diseases of the professional board of dermatology and venereology of China association of integrated Chinese and western medicine (2004) Clinical diagnostic and therapeutic evaluation criteria of melasma (2013 revision). Chin J Dermatovenereol Integr Tradit West Med 3(1):66Google Scholar
- 18.Zhen Y (2008) Treatment for melasma using modified Danzhi Xiaoyao powder: a case series of 30 patients. Hebei J Tradit Chin Med 9(30):975Google Scholar
- 19.Fan H (2008) Application of syndrome differentiation of traditional Chinese medicine in the treatment of melasma: a case series of 72 patients. Chin J Dermatovenereol Integr Tradit West Med 2(7):112Google Scholar
- 20.Liu C, Zhang C (2010) Treatment of Shenlinbaizhu powder and Xuefu-Zhuyu oral liquid for melasma of spleen deficiency and dampness and blood stasis type: a case series of 60 patients. Yunnan J Tradit Chin Med Mater Med 2(31):38–39Google Scholar